GRIFOLS | GRF - Ativo Circulante





Ativo Circulante Alterar Data
Alcon AG USD 6.62B 4M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Amadeus IT EUR 2.64B 324.6M 2026-06
Amarin USD 602.76M 23.26M 2026-06
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Cie Automotive EUR 1.8B 6.22M 2025-12
Demant DKK 10.2B 130M 2026-06
Ence Energia y Celulosa EUR 396.7M 9.37M 2026-03
Essilor EUR 11.24B 770M 2026-06
Ferrovial EUR 6.81B 500M 2026-06
Fresenius EUR 11.61B 456M 2026-06
Fresenius Medical Care EUR 7.69B 418.66M 2026-06
Genmab DKK 2.8B 228M 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.31B 51M 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Inditex EUR 16.09B 402M 2026-03
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Merck EUR 13.77B 393M 2026-06
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.39B 240M 2026-06
UCB EUR 6.05B 733M 2025-12
Viscofan EUR 862.44M 7.79M 2026-06